- OUTLOOK
- Correction 06 July 2020
Temprian Therapeutics: developing a gene-based treatment for vitiligo
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-020-01808-5
This article is part of Nature Outlook: The Spinoff Prize 2020, an editorially independent supplement produced with the financial support of third parties. About this content.
Updates & Corrections
-
Correction 06 July 2020: An earlier version of this profile gave the wrong specialty for Caroline Le Poole and the wrong campus for Northwestern University.
References
Mosenson, J. A. et al. Sci. Transl. Med. 5, 174ra28 (2013).
Henning, S. W. et al. J. Invest. Dermatol. 138, 2531–2539 (2018).